[Acute Measles Encephalitis].
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic methodology or original empirical data
PubMed 42156041 · doi:10.11477/mf.188160960780050532
What was done
This narrative review summarizes the clinical characteristics, prognosis, supportive care, and preventive measures for acute measles encephalitis, focusing on context in Japan.
What was found
The abstract reports no numerical findings. It states qualitatively that acute measles encephalitis presents within days of rash onset with high fever, altered consciousness, seizures, and focal neurological signs, frequently leads to death or long-term neurological sequelae, and has no specific antiviral therapy.
Why it matters
Because acute measles encephalitis has high morbidity and mortality and no specific antiviral treatment, maintaining high two-dose vaccination coverage and targeting unvaccinated adults remain the primary defense.
Limits
This is a narrative review with no original clinical data, sample size, statistical analysis, or described systematic search strategy.
Cited by
- supports Measles infection can cause brain inflammation (encephalitis).